Bradycardia News and Research

RSS
Bradycardia, ("heart slowness"), as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min.
Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces net revenues of $1.9 million for 2014

Egalet announces net revenues of $1.9 million for 2014

Organ-on-a-chip could replace use of animals to test drugs for safety and efficacy

Organ-on-a-chip could replace use of animals to test drugs for safety and efficacy

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Amgen announces phase 3 ivabradine data for treatment of chronic HF

Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

Huntington Memorial Hospital patient implanted with tiny, leadless cardiac pacemaker

Leadless pacemaker technology shows promising performance after 12 months

Leadless pacemaker technology shows promising performance after 12 months

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Novartis presents Phase III results of Signifor LAR therapy in patients with acromegaly

Richard M. Ross Heart Hospital docs implanted smallest heart pacemaker in Columbus woman

Richard M. Ross Heart Hospital docs implanted smallest heart pacemaker in Columbus woman

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

Report describes cardiopulmonary arrest in infant following cyclopentolate eyedrops

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Discovery Laboratories reports net loss of $11.7 million for fourth quarter 2013

Discovery Laboratories reports net loss of $11.7 million for fourth quarter 2013

Clonidine before surgery may control post-surgical pain and child's anxiety

Clonidine before surgery may control post-surgical pain and child's anxiety

London hospital implants world’s first leadless pacemaker

London hospital implants world’s first leadless pacemaker

BMC reduced audible alarms as a way to combat alarm fatigue, improve patient safety

BMC reduced audible alarms as a way to combat alarm fatigue, improve patient safety

iRhythm Technologies’ ZIO Service detects more cardiac arrhythmias than Holter monitor

iRhythm Technologies’ ZIO Service detects more cardiac arrhythmias than Holter monitor

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program